Spots Global Cancer Trial Database for constipation
Every month we try and update this database with for constipation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Preop Laxatives in Robotic Urologic Surgery | NCT05805436 | Prostate Cancer Kidney Cancer Constipation | Polyethylene Gl... | 30 Years - 100 Years | University of Iowa | |
| Cross Sectional Study of Constipation in Advanced Cancer Patients | NCT01399294 | Palliative Care Constipation Traditional Chi... | 18 Years - | Yan Chai Hospital | ||
| Methylnaltrexone for Opioid-induced Constipation in Cancer Patients | NCT01004393 | Neoplasms Constipation Opioid-Related ... | Methylnaltrexon... | 18 Years - | University of Vermont | |
| Epidemiological Study of Colorectal Cancer in WuHan | NCT01863303 | Diarrhea Constipation Melena Neoplasm Colonic Neoplas... Pain | 40 Years - 74 Years | Wuhan Pu-Ai Hospital | ||
| Ultrafast MRI Imaging to Exclude Constipation | NCT02658201 | Constipation | MRI | 6 Years - 18 Years | Sheffield Children's NHS Foundation Trust | |
| The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation | NCT01901341 | Opioid-Induced ... | CB-5945 Placebo | 18 Years - 80 Years | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation | NCT01901302 | Opioid-Induced ... | CB-5945 Placebo | 18 Years - 80 Years | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| The Bowel Research Collaborative Data Tracking System Implementation Study | NCT00728975 | Constipation | - | British Columbia Cancer Agency | ||
| PTNS and PFR in the Treatment of Childhood Constipation | NCT05059756 | Constipation Childhood ALL Pelvic Floor Di... | PTNS Sham PTNS | 10 Years - 14 Years | Shengjing Hospital | |
| Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics | NCT00032682 | Constipation Neoplasms | - | National Institutes of Health Clinical Center (CC) | ||
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00241722 | Bowel Dysfuncti... Constipation | Alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) | NCT02839889 | Cancer Constipation Pain | Naloxegol Placebo | 18 Years - | Hospice of Henderson County, Inc. | |
| Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention | NCT02422329 | Advanced Cancer... | Questionnaires Video Fact Sheet | 18 Years - | M.D. Anderson Cancer Center | |
| Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation | NCT01901328 | Opioid-Induced ... | CB-5945 Placebo | 18 Years - 80 Years | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Prevention of Constipation: Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery | NCT00364169 | Postoperative C... | Degree of const... | 18 Years - | Rigshospitalet, Denmark | |
| Prevention of Constipation: Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery | NCT00364169 | Postoperative C... | Degree of const... | 18 Years - | Rigshospitalet, Denmark | |
| Clinical Trial on Palliative Cancer Patients With Constipation | NCT02795390 | Constipation | Chinese herbal ... Placebo | 18 Years - | Hong Kong Baptist University | |
| S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis | NCT03499808 | Amorphous, Eosi... Constipation Diarrhea Early Satiety Gastrointestina... Hepatomegaly Lymphadenopathy Macroglossia Nausea Primary Systemi... Purpura Recurrent Prima... Refractory Prim... | Isatuximab Laboratory Biom... | 18 Years - | SWOG Cancer Research Network | |
| Epidemiological Study of Colorectal Cancer in WuHan | NCT01863303 | Diarrhea Constipation Melena Neoplasm Colonic Neoplas... Pain | 40 Years - 74 Years | Wuhan Pu-Ai Hospital | ||
| Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention | NCT02422329 | Advanced Cancer... | Questionnaires Video Fact Sheet | 18 Years - | M.D. Anderson Cancer Center | |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00259922 | Bowel Dysfuncti... Constipation | Placebo Alvimopan Alviompan | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Preop Laxatives in Robotic Urologic Surgery | NCT05805436 | Prostate Cancer Kidney Cancer Constipation | Polyethylene Gl... | 30 Years - 100 Years | University of Iowa | |
| Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation | NCT01696643 | Opioid-Induced ... | CB-5945 Placebo | 18 Years - 80 Years | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation | NCT01696643 | Opioid-Induced ... | CB-5945 Placebo | 18 Years - 80 Years | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation | NCT01901341 | Opioid-Induced ... | CB-5945 Placebo | 18 Years - 80 Years | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Ultrafast MRI Imaging to Exclude Constipation | NCT02658201 | Constipation | MRI | 6 Years - 18 Years | Sheffield Children's NHS Foundation Trust | |
| Naloxegol in Cancer Opioid-Induced Constipation | NCT02745353 | Constipation | naloxegol | 18 Years - | University of California, San Diego | |
| Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention | NCT02422329 | Advanced Cancer... | Questionnaires Video Fact Sheet | 18 Years - | M.D. Anderson Cancer Center | |
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00241722 | Bowel Dysfuncti... Constipation | Alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| The FOCCUS Study: "Focusing on Cancers Chemotherapys' Untreated Symptoms" | NCT02121626 | Cancer | 18 Years - 90 Years | Royal Marsden NHS Foundation Trust | ||
| Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients | NCT01189409 | Constipation Cancer | PEG then Senna Senna then PEG | 18 Years - | British Columbia Cancer Agency | |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00259922 | Bowel Dysfuncti... Constipation | Placebo Alvimopan Alviompan | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain | NCT00365820 | Constipation | Tegaserod | 18 Years - | Novartis | |
| Managing Medication-induced Constipation in Cancer: A Clinical Trial | NCT01416909 | Constipation | Laxative Treatm... Standard of Car... Assessment Ques... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Effect of Laser Acupuncture on Constipation in Patients With Advanced Cancer | NCT04318808 | Constipation Advanced Cancer | Laser acupunctu... | 20 Years - | Chang Gung Memorial Hospital | |
| Fiber Formula Study Among Radiation Oncology Patients | NCT00888147 | Constipation | Fiber containin... | 18 Years - | Mayo Clinic | |
| Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00256932 | Bowel Dysfuncti... Constipation | alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication | NCT00101998 | Constipation Bowel Dysfuncti... | alvimopan placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Ultrafast MRI Imaging to Exclude Constipation | NCT02658201 | Constipation | MRI | 6 Years - 18 Years | Sheffield Children's NHS Foundation Trust | |
| Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) | NCT02839889 | Cancer Constipation Pain | Naloxegol Placebo | 18 Years - | Hospice of Henderson County, Inc. | |
| Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects | NCT00135577 | Cancer Bowel Dysfuncti... | alvimopan placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Methylnaltrexone for Opioid-induced Constipation in Cancer Patients | NCT01004393 | Neoplasms Constipation Opioid-Related ... | Methylnaltrexon... | 18 Years - | University of Vermont | |
| Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients | NCT01014559 | Constipation Pain | Oxycodone Nalox... Oxycodone PR Ta... | 18 Years - | Mundipharma SAS |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
